Characterization of the induction of drug-metabolizing enzymes by 2-acetylaminofluorene

Biochim Biophys Acta. 1981 Mar 18;673(3):225-33. doi: 10.1016/0304-4165(81)90330-5.

Abstract

Changes in hepatic drug-metabolizing enzymes after intraperitoneal treatment of rats with 2-acetylaminofluorene have been investigated. This treatment was found to increase microsomal epoxide hydrolase to 762%, cytochrome P-450 to 143%, NADPH-cytochrome c reductase to 160%, cytochrome b5 to 171%, cytoplasmic DT-diaphorase to 229% and soluble glutathione S-transferase activities to 200-250% of control values. These increases were time- and dose-dependent, being maximal after injection of 50 mg 2-acetylaminofluorene/kg body wt. once daily for 5 days. Enzyme markers for the plasma membrane, mitochondria, lysosomes and the soluble cytoplasm were not affected by treatment with 2-acetylaminofluorene. The present study indicates that this induction is different from that obtained with phenobarbital and 3-methylcholanthrene and more closely resembles that seen with trans-stilbene oxide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Acetylaminofluorene / pharmacology*
  • Animals
  • Dose-Response Relationship, Drug
  • Enzyme Induction / drug effects*
  • Male
  • Microsomes, Liver / enzymology*
  • Rats
  • Time Factors

Substances

  • 2-Acetylaminofluorene